Feature | May 01, 2018| Dave Fornell, Editor

Most Popular Cardiology Technology Content in April 2018 on DAIC

Intravascular Lithotripsy May Offer Solution for Calcified Coronary Lesions. Shockwave Medical technology uses sonic bursts to break up calcium in coronary arteries.

The article "Intravascular Lithotripsy May Offer Solution for Calcified Coronary Lesions" was the most popular article posted on the DAIC website in April. Shockwave Medical's technology uses sonic bursts to break up calcium in coronary arteries without vessel trauma associated with angioplasty or atherectomy. 

Here is the list of the most popular articles and videos on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of April 2018. This is based on website analytics of the month’s 176,183 pageviews:

1. Intravascular Lithotripsy May Offer Solution for Calcified Coronary Lesions

2. VIDEO: Sex Differences in Diagnosing Heart Disease in Women

3. University Hospitals Performs Ohio's First Transcatheter Mitral Valve Replacement

4. ACC 2018 Late-Breaking Trials

5. VIDEO: Editor's Choice of Most Innovative New Cardiac Technology at ACC 2018

6. FDA Approves Abbotts Perclose ProGlide Suture-Mediated Closure System for Femoral Vein Closures

7. 360 View of a Cath Lab at Northwestern Medicine Central DuPage Hospital

8. VIDEO: Strategies to Avoid Acute Kidney Injury Caused by Cath Lab Contrast

9. How to Perform Transcaval TAVR Access

10. New Technologies to Improve Atrial Fibrillation Ablation

11. New Pacemaker Technologies

12. Medtronic Cryoballoon Shows Positive Results for Patients With Persistent Atrial Fibrillation

13. VIDEO: Addressing Adult Congenital Heart Referrals

14. Nation's First Heart Failure and Arrhythmia Center Opening in Ohio

15. Boston Scientific Acquires Securus Medical Group Inc.

16. Hospital Consolidation May Increase Access to TAVR, New Cardiac Technologies

17. Abbott Initiates GUIDE-HF Trial for Improved Outcomes With CardioMEMS Monitor

18. VIDEO: Detection of Vulnerable Plaque and Pre-emptive Stenting

19. Philips Warns of Cybersecurity Vulnerabilities in IntelliSpace and iSite PACS Products

20. VIDEO: Use of High Sensitivity Troponin Testing in the Emergency Department

21. FDA Approves Abiomed Impella CP With SmartAssist and Optical Sensor

22. VIDEO: How Consolidation Into Larger Health Systems Can Improve Access to TAVR

23. Will Cardiac MRI Expand?

25. Medtronic Announces Renal Denervation Pivotal Trial for Hypertension Treatment

 

Related Most Popular Cardiac Technology Content

Most Popular Cardiology Topics of 2017

Most Popular Cardiology Technology Content in March 2018 on DAIC

Most Popular Cardiology Technology Content in February 2018 on DAIC

Most Popular Cardiology Technology Content in January 2018 on DAIC

Most Popular Cardiology Technology Content on DAIC in December 2017

Most Popular Cardiac Technology Content in November 2017 on DAIC

 

Related Content

A large subgroup analysis of the VOYAGER PAD randomized clinical trial showed neither a mortality risk nor benefit associated with the use of paclitaxel drug-coated devices (DCD) in the treatment of peripheral artery disease (PAD). The study also found that the benefit of rivaroxaban use on reducing ischemic limb and cardiovascular outcomes was consistent regardless of whether a DCD was used. #TCT2020 #TCTconnect
Feature | Cath Lab | October 18, 2020
October 18, 2020 – A large subgroup analysis of a randomized clinical trial showed neither a mortality risk nor benef
A longitudinal vessel assessment may demonstrate co-existence of multiple plaque morphologies on OCT, including superficial calcification with thrombus, healed plaque, plaque rupture, lipidic plaque with a thin capped fibrous atheroma (TCFA). #TCTconnect #TCT2020

A longitudinal vessel assessment may demonstrate co-existence of multiple plaque morphologies on OCT, including superficial calcification with thrombus, healed plaque, plaque rupture, lipidic plaque with a thin cap fibro-atheroma (TCFA).

News | Cath Lab | October 18, 2020
October 18, 2020 – Data from the...
The DISRUPT CAD III study showed intravascular lithoplasty from Shockwave Medical was effective in breaking up calcified coronary lesions. #TCT2-0

The DISRUPT CAD III study showed intravascular lithoplasty from Shockwave Medical was effective in breaking up calcified coronary lesions.

Feature | Cath Lab | October 16, 2020
October 15, 2020 — Shockwave Medical's Intravascular Lithotripsy (IVL) system to treat severely calcified coronary ar
Videos | Cath Lab | October 16, 2020
This is an example pf the Shockwave Medical Intravascular Lithotripsy (IVL) catheter system designed to break up heav
Videos | Cath Lab | July 15, 2020
Richard Botto, CVT, RCSA, chief cardiovascular technologist, division of cardiology, cardiac cath lab, offers an over
Videos | Cath Lab | July 13, 2020
The Vieussens’ arterial ring (VAR) is a connection between the conus artery and the left anterior descending (LAD) co
News | Cath Lab | July 06, 2020
July 6, 2020 — Black patients who undergo percutaneous coronary intervention (PCI) are at an increased risk for major
TCT cancels in-person meeting and goes virtual due to COVID-19
News | Cath Lab | May 27, 2020
May 27, 2020 — To ensure the health and safety of all attendees due to the ongoing COVID-19 (SARS-CoV-2) pandemic, th